Analysts’ Viewpoint
Increase in prevalence of genetic disorders and rise in awareness about personalized medicine is driving the genetic testing services market size. Advancements in technology, such as next-generation sequencing and gene editing techniques, have improved the accuracy, efficiency, and affordability of genetic testing, further fueling market expansion.
Increase in adoption of direct-to-consumer gene testing kits has made genetic testing more accessible to individuals. These kits allow consumers to obtain genetic information from the comfort of their homes, enabling personalized health management and ancestry exploration, thereby boosting the genetic testing services industry.
Market players are adopting partnership and collaboration strategies to increase revenue. They are also focusing of product portfolio expansion to broaden customer base.
Genetic testing services refer to the analysis of an individual's genetic material, such as DNA testing, to identify genetic disorders, predict disease risks, and guide personalized treatment plans. These services have gained significant importance in the field of healthcare due to their potential to provide valuable insights into an individual's genetic makeup and help making informed medical decisions.
DNA analysis services encompass a wide range of applications, including carrier testing, prenatal testing, diagnostic testing, predictive testing, and pharmacogenomic testing. Carrier testing helps identify individuals who carry a gene for a specific genetic disorder and may pass it on to their offspring.
Prenatal testing involves examining fetal DNA to detect genetic abnormalities or conditions before birth. Diagnostic testing is used to confirm or rule out a suspected genetic disorder based on symptoms or family history.
Increase in prevalence of genetic disorders across the globe is fueling the global genetic testing services market. Genetic testing plays a crucial role in diagnosing and managing these disorders, enabling early intervention and personalized treatment plans.
Genetic testing helps healthcare providers make informed decisions about patient care, leading to improved outcomes, by identifying specific genetic variations and mutations. Continuous rise in incidence of genetic diseases is expected to lead to the genetic testing services market growth, resulting in innovation in the field.
Rise in demand for personalized medicine offers lucrative genetic testing services market opportunities to market players. Personalized medicine aims to customize healthcare based on an individual's unique genetic information. Genetic testing plays a critical role in this approach by providing insights into an individual's genetic makeup, disease risks, and treatment responses.
Healthcare providers can make more informed decisions about disease prevention, diagnosis, and treatment, by utilizing genetic testing results, leading to improved patient outcomes. Surge in adoption of personalized medicine practices is driving the genetic testing services market demand and shaping the future of healthcare.
Technological advancements in genetic testing includes next-generation gene sequencing services, microarray analysis, and PCR. These advancements have significantly improved the accuracy, speed, and affordability of genetic testing. They have made genetic testing more accessible to healthcare providers and patients, driving market progress.
The enhanced capabilities of these technologies have facilitated high adoption of genetic testing services and expanded their applications in various healthcare settings, contributing to the genetic testing services market development.
According to the latest genetic testing services market trends, the prenatal testing product segment is estimated to dominate the industry during the forecast period. Prenatal testing experiences high demand during pregnancy due to several factors.
Expectant parents seek prenatal testing to assess the health and development of the fetus, identify potential genetic disorders or chromosomal abnormalities, and make informed decisions about the pregnancy. This is expected to influence the genetic testing services market statistics.
According to the latest genetic testing services market forecast, North America is expected to hold the largest market share during 2022-2031. This can be ascribed to factors such as advanced healthcare infrastructure, increased adoption of genetic testing, favorable reimbursement policies, and high prevalence of genetic disorders in the region.
North America's strong market presence reflects its significant contribution in the growth and development of genetic testing services.
Asia Pacific is expected to register a substantial genetic testing services market CAGR during the forecast period. Large population base, increase in disposable income, rise in awareness about genetic disorders, and improvements in healthcare infrastructure contribute to the regional market expansion. Rise in healthcare expenditure and focus on personalized medicine in countries such as China, India, and Japan are also augmenting market statistics.
Advancements in technology and availability of cost-effective genetic testing solutions are propelling market demand in the region. Collaborations between international and local players are also fostering market development. Overall, these factors are likely to provide significant growth opportunities to the industry players during the forecast period.
Small number of dominant players hold substantial market share, indicating a consolidated industry. These companies prioritize research and development by making significant investments in this area.
Players in the market focus on expanding their product portfolios and adopting mergers and acquisitions strategies. This allows them to enhance their offerings and gain a competitive edge.
Companies profiled in the global genetic testing services market include Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories, Inc., Eurofins Scientific, Ambry Genetics, Illumina, Inc., and 23andMe, Inc.
Key players have been profiled in the genetic testing services market report based on parameters such as product portfolio, recent developments, financial overview, company overview, business strategies, and business segments.
Attribute | Detail |
---|---|
Size in 2022 |
US$ 15.0 Bn |
Forecast (Value) in 2031 |
More than US$ 31.5 Bn |
Growth Rate (CAGR) |
8.4% |
Forecast Period |
2023-2031 |
Historical Data Available for |
2017-2022 |
Quantitative Units |
US$ Bn for Value |
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
The global industry was valued at US$ 15.0 Bn in 2022
It is projected to reach more than US$ 31.5 Bn by 2031
It is anticipated grow at a CAGR of 8.4% from 2023 to 2031
The prenatal testing segment held the largest share in 2022
North America is expected to be an attractive region
Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories, Inc., Eurofins Scientific, Ambry Genetics, Illumina, Inc., and 23andMe, Inc. are the prominent players in the market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Genetic Testing Services Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Genetic Testing Services Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
5.3. Technological Advancements
5.4. COVID-19 Impact Analysis
6. Global Genetic Testing Services Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2017 - 2031
6.3.1. Prenatal Testing
6.3.2. New Born Screening
6.3.3. Predictive & Presymptomatic Testing
6.3.4. Pharmacogenomic Testing
6.3.5. Others
6.4. Market Attractiveness Analysis, by Test Type
7. Global Genetic Testing Services Market Analysis and Forecast, by Service Provider
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Service Provider, 2017-2031
7.3.1. Hospital-based Laboratories
7.3.2. Diagnostic Laboratories
7.3.3. Specialty Clinics
7.3.4. Others
7.4. Market Attractiveness Analysis, by Service Provider
8. Global Genetic Testing Services Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
8.3.1. Oncology
8.3.2. Infectious Diseases
8.3.3. Autoimmune Diseases
8.3.4. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Genetic Testing Services Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Genetic Testing Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Test Type, 2017-2031
10.2.1. Prenatal Testing
10.2.2. New Born Screening
10.2.3. Predictive & Presymptomatic Testing
10.2.4. Pharmacogenomic Testing
10.2.5. Others
10.3. Market Value Forecast, by Service Provider, 2017-2031
10.3.1. Hospital-based Laboratories
10.3.2. Diagnostic Laboratories
10.3.3. Specialty Clinics
10.3.4. Others
10.4. Market Value Forecast, by Application, 2017-2031
10.4.1. Oncology
10.4.2. Infectious Diseases
10.4.3. Autoimmune Diseases
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Test Type
10.6.2. By Service Provider
10.6.3. By Application
10.6.4. By Country
11. Europe Genetic Testing Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017-2031
11.2.1. Prenatal Testing
11.2.2. New Born Screening
11.2.3. Predictive & Presymptomatic Testing
11.2.4. Pharmacogenomic Testing
11.2.5. Others
11.3. Market Value Forecast, by Service Provider, 2017-2031
11.3.1. Hospital-based Laboratories
11.3.2. Diagnostic Laboratories
11.3.3. Specialty Clinics
11.3.4. Others
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Oncology
11.4.2. Infectious Diseases
11.4.3. Autoimmune Diseases
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Test Type
11.6.2. By Service Provider
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Genetic Testing Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017-2031
12.2.1. Prenatal Testing
12.2.2. New Born Screening
12.2.3. Predictive & Presymptomatic Testing
12.2.4. Pharmacogenomic Testing
12.2.5. Others
12.3. Market Value Forecast, by Service Provider, 2017-2031
12.3.1. Hospital-based Laboratories
12.3.2. Diagnostic Laboratories
12.3.3. Specialty Clinics
12.3.4. Others
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Oncology
12.4.2. Infectious Diseases
12.4.3. Autoimmune Diseases
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Test Type
12.6.2. By Service Provider
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Genetic Testing Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017-2031
13.2.1. Prenatal Testing
13.2.2. New Born Screening
13.2.3. Predictive & Presymptomatic Testing
13.2.4. Pharmacogenomic Testing
13.2.5. Others
13.3. Market Value Forecast, by Service Provider, 2017-2031
13.3.1. Hospital-based Laboratories
13.3.2. Diagnostic Laboratories
13.3.3. Specialty Clinics
13.3.4. Others
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Oncology
13.4.2. Infectious Diseases
13.4.3. Autoimmune Diseases
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Test Type
13.6.2. By Service Provider
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Genetic Testing Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Test Type, 2017-2031
14.2.1. Prenatal Testing
14.2.2. New Born Screening
14.2.3. Predictive & Presymptomatic Testing
14.2.4. Pharmacogenomic Testing
14.2.5. Others
14.3. Market Value Forecast, by Service Provider, 2017-2031
14.3.1. Hospital-based Laboratories
14.3.2. Diagnostic Laboratories
14.3.3. Specialty Clinics
14.3.4. Others
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Oncology
14.4.2. Infectious Diseases
14.4.3. Autoimmune Diseases
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Test Type
14.6.2. By Service Provider
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Laboratory Corporation of America Holdings
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Service Provider Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Quest Diagnostics Incorporated
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Service Provider Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Genomic Health, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Service Provider Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. NeoGenomics Laboratories, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Service Provider Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Eurofins Scientific
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Service Provider Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Ambry Genetics
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Service Provider Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Illumina, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Service Provider Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. 23andMe, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Service Provider Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
List of Tables
Table 01: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 02: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 03: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 04: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Region, 2017-2032
Table 05: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Country, 2017-2032
Table 06: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 07: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 08: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 09: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
Table 10: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 11: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 12: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 13: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
Table 14: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 15: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 16: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 17: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
Table 18: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 19: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 20: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 21: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
Table 22: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 23: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 24: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
List of Figures
Figure 01: Global Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 02: Genetic Testing Services Market Value Share, by Test Type, 2022
Figure 03: Genetic Testing Services Market Value Share, by Service Provider, 2022
Figure 04: Genetic Testing Services Market Value Share, by Application, 2022
Figure 05: Global Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 06: Global Genetic Testing Services Market Revenue (US$ Mn), by Prenatal Testing, 2017-2032
Figure 07: Global Genetic Testing Services Market Revenue (US$ Mn), by New Born Screening, 2017-2032
Figure 08: Global Genetic Testing Services Market Revenue (US$ Mn), by Predictive & Presymptomatic Testing, 2017-2032
Figure 09: Global Genetic Testing Services Market Revenue (US$ Mn), by Pharmacogenomic Testing, 2017-2032
Figure 10: Global Genetic Testing Services Market Revenue (US$ Mn), by Others, 2017-2032
Figure 11: Global Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 12: Global Genetic Testing Services Market Revenue (US$ Mn), by Service Provider, 2017-2032
Figure 13: Global Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2017-2032
Figure 14: Global Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032
Figure 15: Global Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032
Figure 16: Global Genetic Testing Services Market Value Share Analysis, by Region, 2022 and 2032
Figure 17: Global Genetic Testing Services Market Attractiveness Analysis, by Region, 2023-2032
Figure 18: North America Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 19: North America Genetic Testing Services Market Value Share Analysis, by Country, 2022 and 2032
Figure 20: North America Genetic Testing Services Market Attractiveness Analysis, by Country, 2023-2032
Figure 21: North America Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 22: North America Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 23: North America Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032
Figure 24: North America Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032
Figure 25: North America Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032
Figure 26: North America Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032
Figure 27: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 28: Europe Genetic Testing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
Figure 29: Europe Genetic Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
Figure 30: Europe Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 31: Europe Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 32: Europe Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032
Figure 33: Europe Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032
Figure 34: Europe Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032
Figure 35: Europe Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032
Figure 36: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 37: Asia Pacific Genetic Testing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
Figure 38: Asia Pacific Genetic Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
Figure 39: Asia Pacific Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 40: Asia Pacific Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 41: Asia Pacific Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032
Figure 42: Asia Pacific Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032
Figure 43: Latin America Genetic Testing Services Market Value Share Analysis, by Indication, 2022 and 2032
Figure 44: Latin America Genetic Testing Services Market Attractiveness Analysis, Indication, 2023-2032
Figure 45: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 46: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
Figure 47: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
Figure 48: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 49: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 50: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032
Figure 51: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032
Figure 52: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032
Figure 53: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032